Issued Patents All Time
Showing 25 most recent of 31 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11766479 | Therapeutic use of antibodies against ENPP3 | Zuoxiang Xiao, Jiaping Peng, Dongwen Zhou | 2023-09-26 |
| 11639337 | Bicyclic heteroaryl derivatives and preparation and uses thereof | Jia-Ning Xiang, Xuesong Xu | 2023-05-02 |
| 11578139 | Antibodies against ENPP3 and uses thereof | Zuoxiang Xiao, Jiaping Peng, Dongwen Zhou | 2023-02-14 |
| 11401249 | Bicyclic heteroaryl derivatives and preparation and uses thereof | Jia-Ning Xiang, Xuesong Xu | 2022-08-02 |
| 11306095 | Use of pteridinone derivative serving as EGFR inhibitor | Honglin Li, Yufang Xu, Zhenjiang ZHAO, Yuqiong Xu, Deheng Sun +2 more | 2022-04-19 |
| 10881817 | Secretion loosening and cough segmenting therapy | Maarten Leonardus Christian Brand, Michael Edward Colbaugh, James Garsteck | 2021-01-05 |
| 10882832 | Bicyclic heteroaryl derivatives and preparation and uses thereof | Jia-Ning Xiang, Xuesong Xu | 2021-01-05 |
| 10759765 | Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute | Dawei Ma, Mengyang Fan, Haibo Wu, Junli Yin, Xi Jiang +2 more | 2020-09-01 |
| 10759805 | Compounds that are ERK inhibitors | Jongwon Lim, Xianhai Huang, Ronald D. Ferguson, Christopher W. Boyce, Phieng Siliphaivanh +4 more | 2020-09-01 |
| 10640476 | Bicyclic heteroaryl derivatives and preparation and uses thereof | Jia-Ning Xiang, Xuesong Xu | 2020-05-05 |
| 10500577 | Oxalic amide ligands, and uses thereof in copper-catalyzed coupling reaction of aryl halides | Dawei Ma, Mengyang Fan, Haibo Wu, Junli Yin, Shanghua XIA | 2019-12-10 |
| 10344039 | Macrocyclic spirocarbamate derivatives as factor XIa inhibitors, pharmaceutically acceptable compositions and their use | Amjad Ali, Yeon-Hee Lim, Jiayi Xu | 2019-07-09 |
| 10214512 | Factor XIA inhibitors | Jiayi Xu, Amjad Ali, Ying-Duo Gao, Scott D. Edmondson, Eric Mertz +9 more | 2019-02-26 |
| 10065967 | Compounds that are ERK inhibitors | Jongwon Lim, Xianhai Huang, Ronald D. Ferguson, Christopher W. Boyce, Phieng Siliphaivanh +4 more | 2018-09-04 |
| 9827290 | Compositions and methods relating to induction of intestinal stem cell homeogenesis and/or regeneration | Jian-Guo Geng, Li Ma | 2017-11-28 |
| 9745307 | Compounds that are ERK inhibitors | Jongwon Lim, Xianhai Huang, Ronald D. Ferguson, Christopher W. Boyce, Phieng Siliphaivanh +4 more | 2017-08-29 |
| 9676780 | Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties | Amjad Ali, Michael Man-Chu Lo, Yeon-Hee Lim, Andrew Stamford, Rongze Kuang +19 more | 2017-06-13 |
| 9670213 | Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor | Honglin Li, Yufang Xu, Zhenjiang ZHAO, Xiaofeng Liu, Fang Bai +3 more | 2017-06-06 |
| 9290454 | Substituted isoquinolines as CRTH2 receptor modulators | Xianhai Huang, Anandan Palani, Ashwin U. Rao, Hongjun Zhang | 2016-03-22 |
| 9233979 | Compounds that are ERK inhibitors | Kevin J. Wilson, David J. Witter, Phieng Siliphaivanh, Kathryn Lipford, David L. Sloman +18 more | 2016-01-12 |
| 9226922 | Compounds that are ERK inhibitors | Kevin J. Wilson, David J. Witter, Matthew H. Daniels, Angie R. Angeles, Phieng Siliphaivanh +16 more | 2016-01-05 |
| 9023865 | Compounds that are ERK inhibitors | Jongwon Lim, Elizabeth H. Kelley, Joey L. Methot, Hua Zhou, Alessia Petrocchi +17 more | 2015-05-05 |
| 8927559 | Quinazolinone-type compounds as CRTH2 antagonists | Robert G. Aslanian, Christopher W. Boyce, Robert Mazzola, Brian McKittrick, Kevin D. McCormick +20 more | 2015-01-06 |
| 8673900 | Gamma secretase modulators | Zhaoning Zhu, William J. Greenlee, Xianhai Huang, Jun Qin, Xiaoxiang Liu +9 more | 2014-03-18 |
| 8598158 | Fused tricyclic compounds for the treatment of inflammatory disorders | Dong Xiao, Anandan Palani, Robert G. Aslanian, Sylvia Degrado, Xianhai Huang +2 more | 2013-12-03 |